Literature DB >> 191909

Sesquiterpene antitumor agents: inhibitors of cellular metabolism.

K H Lee, I H Hall, E C Mar, C O Starnes, S A ElGebaly, T G Waddell, R I HADGRAFT, C G Ruffner, I Weidner.   

Abstract

Helenalin and tenulin injected into CF1 male mice bearing Ehrlich ascites tumors inhibit DNA synthesis and DNA polymerase enzymatic activity in the tumor cells. Helenalin inhibited protein synthesis. Both drugs increased the concentration of adenosine 3',5'-monophosphate, and interfered with glycolytic and mitochondrial energy processes. Cholesterol synthesis was also inhibited, resulting in lower serum cholesterol levels in tumor-bearing animals. Data obtained in vitro indicate that the cyclopentenone-bearing sesquiterpene lactone and related compounds do not alkylate puring bases of nucleic acids but rather undergo a Michael-type addition reaction with the sulfhydryl groups of reduced glutathione and l-cysteine. Thus, the inhibition of cellular enzyme activities and metabolism that has been observed with these drugs might be explained by the occurrence of a Michael-type teaction.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191909     DOI: 10.1126/science.191909

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  26 in total

1.  Cytotoxic and NF-κB inhibitory sesquiterpene lactones from Piptocoma rufescens.

Authors:  Yulin Ren; Ulyana Muñoz Acuña; Francisco Jiménez; Ricardo García; Melciades Mejía; Heebyung Chai; Judith C Gallucci; Norman R Farnsworth; Djaja D Soejarto; Esperanza J Carcache de Blanco; A Douglas Kinghorn
Journal:  Tetrahedron       Date:  2012-01-26       Impact factor: 2.457

2.  Identifying functional domains within terpene cyclases using a domain-swapping strategy.

Authors:  K Back; J Chappell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Phytotoxic properties of cnicin, a sesquiterpene lactone fromcentaurea maculosa (spotted knapweed).

Authors:  R G Kelsey; L J Locken
Journal:  J Chem Ecol       Date:  1987-01       Impact factor: 2.626

4.  Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis.

Authors:  Chunyong Ding; Yusong Zhang; Haijun Chen; Zhengduo Yang; Christopher Wild; Na Ye; Corbin D Ester; Ailian Xiong; Mark A White; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2013-10-31       Impact factor: 7.446

Review 5.  Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach.

Authors:  Kuo-Hsiung Lee
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

Review 6.  Eupatorium cannabinum L. A review emphasizing the sesquiterpene lactones and their biological activity.

Authors:  H J Woerdenbag
Journal:  Pharm Weekbl Sci       Date:  1986-10-17

7.  Combined effects of anticancer drugs and new synthetic α-methylene-δ-lactones on MCF-7 cells.

Authors:  Katarzyna Gach; Jacek Szymański; Dorota Pomorska; Angelika Długosz; Jakub Modranka; Tomasz Janecki; Anna Janecka
Journal:  Tumour Biol       Date:  2015-03-06

8.  Synthesis and cytotoxic evaluation of a series of gamma-substituted gamma-aryloxymethyl-alpha-methylene-gamma-butyrolactones against cancer cells.

Authors:  C C Tzeng; K H Lee; T C Wang; C H Han; Y L Chen
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

9.  Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz.

Authors:  Jiang-Jiang Qin; Hui-Zi Jin; Ying Huang; Shou-De Zhang; Lei Shan; Sukesh Voruganti; Subhasree Nag; Wei Wang; Wei-Dong Zhang; Ruiwen Zhang
Journal:  Eur J Med Chem       Date:  2013-08-11       Impact factor: 6.514

10.  Increased intracellular Ca2+ signaling caused by the antitumor agent helenalin and its analogues.

Authors:  G Powis; A Gallegos; R T Abraham; C L Ashendel; L H Zalkow; G B Grindey; R Bonjouklian
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.